Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

Share Price is delayed by 15 minutes
Get Live Data
76.50    1.00 (1.32%)
Bid:
75.00
Ask:
78.00
Spread: 3.00 (4.00%)
Market Cap: £10.23m
ARC Live PriceLast checked at - London Stock Exchange

Intraday Arcontech Group Share Chart

Statement re Arcontech

15 Sep 2008 07:00

RNS Number : 3768D
Knowledge Technology Solutions PLC
15 September 2008
 



15 September 2008 

Knowledge Technology Solutions plc ("KTS" or "the Company")

Arcontech/KTS Completes Integration with Equiduct feeds

KTS is pleased to announce that it's wholly owned subsidiary Arcontech, a real-time software specialist providing products and bespoke systems for collection, processing, distribution and presentation of time-sensitive financial markets data, has completed the introduction of new feed handlers to integrate Equiduct's data into its CityVision product suite. This gives customers' access to the real-time VBBO (Volume-weighted Best Bid/Offer), hybrid order book and trade feeds from the new pan-European stock exchange via off-the-shelf CityVision products, such as Excelerator for real-time data in Microsoft Excel and the CityVision Calculation Engine, which offers high speed data processing to support price comparisons and algorithm trading decisions. The new development will also provide access to the Equiduct feed via powerful CityVision DNA (dot net api) module, which allows developers using Microsoft's .net languages rapidly to create high performance applications very simply. It will also enable CityVision to publish Equiduct data directly onto the Reuters RMDS platform instead of via vendors, thus considerably reducing the latency for delivery. Andrew Miller, managing director of Arcontechcommented: 

"This is another example of the benefits of our independent market data platform components approach. Deploying our FIX engine interface and feed server API greatly reduces development time for basic feed handling and, once that is done correctly, the data is immediately available to the rest of our components. We are now ready, well ahead of the Equiduct live date, to work with firms wishing to take advantage of integration with the new exchange."

For further information please contact:

Arcontech/KTS

Andrew Miller

020 7256 2300

Smithfield (PR advisers to Arcontech)

Katie Hunt / Will Henderson

020 7360 4900

  

Notes for Editors

About Arcontech

Arcontech, a wholly owned subsidiary of KTS, is an award-winning developer of mission-critical software for real-time market data transmission and trading. Its diverse clients cover a wide range of users of market data, including leading City institutions, National Government, Banks, Brokers and Data Vendors through to Internet Bookmakers.

Formed in 1979, Arcontech has thrived due to timely delivery of dependable, cost-effective solutions to the financial community.

Arcontech installed its first digital market data products in 1983 and has continually developed new, innovative systems and products, adopting leading edge technology, proven in the marketplace. 

Arcontech has experience of a wide range of technical concepts and applications and the ability to combine the best from each. Key areas of expertise include: 

Market data infrastructure 

Contracts for difference trading and spread betting systems 

Real-time internet distribution 

Multi vendor data contribution 

Platform integration and protocol conversion 

Consulting and custom development 

For more information please visit www.arcontech.com and www.ktsplc.com. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKBKQPBKDPCD
Date   Source Headline
7th Sep 20217:00 amRNSExercise of Options, Director/PDMR Shareholding
1st Sep 20214:41 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSFinal Results
10th Aug 20217:00 amRNSNotice of Results
12th Mar 202112:16 pmRNSHolding(s) in Company
23rd Feb 20217:00 amRNSInterim Results
22nd Jan 20214:30 pmRNSIssue of Equity
16th Oct 20207:00 amRNSAgreement to upgrade longstanding Tier 1 Client
5th Oct 20203:03 pmRNSGrant of Options
2nd Oct 202011:05 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSNew client win to contribute data to Factset
29th Sep 202010:53 amRNSResult of AGM
10th Sep 20207:00 amRNSIssue of Equity & PDMR Shareholding
8th Sep 20207:00 amRNSPosting of Annual Report & Notice of AGM
2nd Sep 20207:00 amRNSFinal Results
27th Aug 20201:59 pmRNSNotice of Results
20th Jul 20207:00 amRNSBoard appointment
15th Jul 20207:00 amRNSTrading Update / Notice of Results
1st Jun 20207:00 amRNSDirectorate change & Appointment of CoSec
16th Mar 20204:40 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
5th Mar 20207:00 amRNSInterim Results
28th Feb 20203:28 pmRNSTrading Update & Notice of Results
2nd Dec 20194:20 pmRNSMichael Levy
3rd Oct 20191:28 pmRNSResult of AGM
27th Sep 20191:14 pmRNSGrant of Options
11th Sep 20197:00 amRNSHolding(s) in Company
2nd Sep 20197:00 amRNSPosting of Annual Report & Notice of AGM
22nd Aug 20197:00 amRNSFinal Results
11th Jul 20197:00 amRNSTrading Update and Notice of Results
15th May 20197:00 amRNSDirector/PDMR Shareholding
8th May 20194:21 pmRNSHolding(s) in Company
29th Mar 20192:27 pmRNSDirector/PDMR Shareholding
27th Feb 20197:00 amRNSInterim Results
4th Feb 20197:00 amRNSIncreased client uptake of Excelerator
4th Dec 20189:56 amRNSHolding(s) in Company
3rd Dec 20184:13 pmRNSGrant of Options
27th Sep 201812:20 pmRNSResult of AGM
31st Aug 20187:00 amRNSPosting of Annual Report & Notice of AGM
23rd Aug 20187:00 amRNSFinal Results
13th Jul 20182:47 pmRNSDirector/PDMR Shareholding
10th Jul 20187:00 amRNSTrading Update / Notice of Results
20th Apr 20188:30 amRNSIssue of Equity and Director / PDMR Shareholding
29th Mar 20182:02 pmRNSDirector/PDMR Shareholding
1st Mar 201811:00 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSHalf-year Report
12th Oct 20173:32 pmRNSIssue of Equity & Director/PDMR Shareholding
27th Sep 20175:23 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.